FBLG · FibroBiologics, Inc. · Exempt Offerings
$0.92
-0.02 (-2.56%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the condensed consolidated financial statements. While management has implemented plans to obtain additional funding, these plans are not sufficient to alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 31, 2026
Market Cap
$6.12M
Shares
6.66M
Volume · Oct 20
94.09K
Avg daily vol (3M)
209.47K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-10-13 | New | Pharmaceuticals | $1,200,000 | $1,200,000 | 06b |
| 2026-09-16 | New | Pharmaceuticals | $500,001 | $500,001 | 06b |
| 2026-06-29 | New | Pharmaceuticals | $3,000,000 | $3,000,000 | 06b |
| 2025-12-16 | New | Pharmaceuticals | $1,725,001 | $1,725,001 | 06b |
| 2025-12-03 | New | Pharmaceuticals | $1,500,000 | $1,500,000 | 06b |
| 2025-12-03 | New | Pharmaceuticals | $4,000,000 | $4,000,000 | 06b |
Showing 1–6 of 6 filings